Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial

Authors: De Jaeghere, Emiel A., Hamerlinck, Hannelore, Tuyaerts, Sandra, Lippens, Lien, Van Nuffel, An M.T., Baiden-Amissah, Regina, Vuylsteke, Peter, Henry, Stéphanie, Trinh, Xuan Bich, van Dam, Peter A., Aspeslagh, Sandrine, De Caluwé, Alex, Naert, Eline, Lambrechts, Diether, Hendrix, An, De Wever, Olivier, Van de Vijver, Koen K., Amant, Frédéric, Vandecasteele, Katrien, Verhasselt, Bruno, Denys, Hannelore G.

Source: In Gynecologic Oncology December 2024 191:275-286

Immunotherapy efficacy and toxicity: Reviewing the evidence behind patient implementable strategies

Authors: Verhaert, Marthe August Marianne, Aspeslagh, Sandrine

Source: In European Journal of Cancer September 2024 209

Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma

Authors: Verheijden, Rik J., Burgers, Femke H., Janssen, Josephine C., Putker, Anouk E., Veenstra, Sophie P.G.R., Hospers, Geke A.P., Aarts, Maureen J.B., Hehenkamp, Karel W., Doornebosch, Veerle L.E., Verhaert, Marthe, van den Berkmortel, Franchette W.P.J., Chatzidionysiou, Katerina, Llobell, Arturo, Barros, Milton, Maria, Alexandre T.J., Takeji, Akari, García Morillo, José-Salvador, Lidar, Merav, van Eijs, Mick J.M., Blank, Christian U., Aspeslagh, Sandrine, Piersma, Djura, Kapiteijn, Ellen, Labots, Mariette, Boers-Sonderen, Marye J., van der Veldt, Astrid A.M., Haanen, John B.A.G., May, Anne M., Suijkerbuijk, Karijn P.M.

Source: In European Journal of Cancer August 2024 207

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus

Authors: Desmedt, Valérie, Jauregui-Amezaga, Aranzazu, Fierens, Liselotte, Aspeslagh, Sandrine, Dekervel, Jeroen, Wauters, Els, Peeters, Marc, Sabino, Joao, Crapé, Lara, Somers, Michael, Hoorens, Anne, Dutré, Joris, Lobatón, Triana

Source: European journal of cancer. 187:36-57

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194254027.0x000001&indx=1&recIds=ETOCvdc_100194254027.0x000001

Systemic treatment and radiotherapy for patients with non-small cell lung cancer (NSCLC) and HIV infection – A systematic review

Authors: Brandão, Mariana, Durieux, Valérie, Auprih, Maša, Fozza, Alessandra, Dauby, Nicolas, Cuccia, Francesco, Aspeslagh, Sandrine, Verhaert, Marthe, Giaj-Levra, Niccolò

Source: Lung cancer. 178:75-86

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186488501.0x000001&indx=1&recIds=ETOCvdc_100186488501.0x000001

Severe treatment-induced inflammatory polyarthritis in advanced melanoma patients: 2 case reports

Authors: Lauwyck, Justine, Schreuer, Max, Meric de Bellefon, Laurent, Van Erps, Joanna, Neyns, Bart, Aspeslagh, Sandrine

Source: Melanoma research. 32(3):200-204

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100155461023.0x000001&indx=1&recIds=ETOCvdc_100155461023.0x000001

Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.

Authors: De Jaeghere, Emiel A., Tuyaerts, Sandra, Van Nufel, An M. T., Belmans, Ann, Bogaerts, Kris, Baiden-Amissah, Regina, Lippens, Lien, Vuylsteke, Peter, Henry, Stéphanie, Trinh, Xuan Bich, van Dam, Peter A., Aspeslagh, Sandrine, De Caluwé, Alex, Naert, Eline, Lambrechts, Diether, Hendrix, An, De Wever, Olivier, Van de Vijver, Koen K., Amant, Frédéric, Vandecasteele, Katrien

Source: Cancer Immunology, Immunotherapy; Jan2025, Vol. 74 Issue 1, p1-4, 4p

Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study

Authors: Da Silva Lopes, André Manuel, Colomer-Lahiguera, Sara, Mederos Alfonso, Nuria, Aedo-Lopez, Veronica, Spurrier-Bernard, Gilliosa, Tolstrup, Lærke Kjær, Pappot, Helle, Aspeslagh, Sandrine, Rogiers, Anne, Neyns, Bart, Haanen, John B., Mitchell, Sandra A., Addeo, Alfredo, Michielin, Olivier, Eicher, Manuela

Source: In European Journal of Cancer November 2021 157:225-237

A Late Dermatologic Presentation of Bullous Pemphigoid Induced by Anti-PD-1 Therapy and Associated with Unexplained Neurological Disorder

Authors: Wang, Xiaoxiao, Suppa, Mariano, Bruderer, Pascal, Sirtaine, Nicolas, Aspeslagh, Sandrine, Kerger, Joseph

Source: Case reports in oncology. 14(2):861-867

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100128197414.0x000001&indx=1&recIds=ETOCvdc_100128197414.0x000001

C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting

Authors: Lauwyck, Justine, Beckwée, Aline, Santens, Arno, Schwarze, Julia Katharina, Awada, Gil, Vandersleyen, Valérie, Aspeslagh, Sandrine, Neyns, Bart

Source: Melanoma research. 31(4):371-377

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184610144.0x000001&indx=1&recIds=ETOCvdc_100184610144.0x000001

Sarcoid-like reaction in a BRAF V600E-mutated metastatic melanoma patient during treatment with BRAF/MEK-targeted therapy

Authors: Tijtgat, Jens, Schwarze, Julia Katharina, Awada, Gil, Neyns, Bart, Aspeslagh, Sandrine

Source: Melanoma research. 31(3):272-276

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184610012.0x000001&indx=1&recIds=ETOCvdc_100184610012.0x000001

Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockade

Authors: Belcaid, Laila, Garaud, Soizic, Kerger, Joseph, Spyridon, Sideris, Aspeslagh, Sandrine

Source: Acta clinica belgica. 76(2):144-148

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100116576697.0x000001&indx=1&recIds=ETOCvdc_100116576697.0x000001

Understanding genetic determinants of resistance to immune checkpoint blockers

Authors: Aspeslagh, Sandrine, Chabanon, Roman M., Champiat, Stéphane, Postel-Vinay, Sophie ^*

Source: In Seminars in Cancer Biology October 2020 65:123-139

Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients

Authors: Rembielak, Agata, Yau, Thomas, Akagunduz, Baran, Aspeslagh, Sandrine, Colloca, Giuseppe, Conway, Aoife, Danwata, Falalu, del Marmol, Veronique, O'Shea, Chuck, Verhaert, Marthe, Zic, Rado, Livesey, Dan

Source: Journal of geriatric oncology. 14(4)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190051497.0x000001&indx=1&recIds=ETOCvdc_100190051497.0x000001

Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis

Authors: de Azambuja, Evandro, Brandão, Mariana, Wildiers, Hans, Laenen, Annouschka, Aspeslagh, Sandrine, Fontaine, Christel, Collignon, Joelle, Lybaert, Willem, Verheezen, Jolanda, Rutten, Annemie, Vuylsteke, Peter, Goeminne, Jean-Charles, Demey, Wim, Van Beckhoven, Dominique, Deblonde, Jessika, Rottey, Sylvie, Geukens, Tatjana, Punie, Kevin, Bafort, Kristof, Belkhir, Leïla, Bossuyt, Nathalie, Colombie, Vincent, Daubresse, Christine, Dauby, Nicolas, De Munter, Paul, Delmarcelle, Didier, Delvallee, Mélanie, Demeester, Rémy, Delefortrie, Quentin, Dugernier, Thierry, Holemans, Xavier, Louviaux, Ingrid, Machurot, PierreYves, Minette, Philippe, Mokrane, Saphia, Nachtergal, Catherine, Noirhomme, Séverine, Piérard, Denis, Rossi, Camelia, Schirvel, Carole, Sermijn, Erica, Staelens, Frank, Triest, Filip, Van Goethem, Nina, Van Praet, Jens, Vanhoenacker, Anke, Verstraete, Roeland, Willems, Elise, Wyndham-Thomas, Chloé

Source: In ESMO Open 2020 5(5)

Pneumocystis infection in two patients treated with both immune checkpoint inhibitor and corticoids

Authors: Sadek, Maroun, Loizidou, Angela, Drowart, Annie, den Wijngaert, Sigi, Gomez-Galdon, Maria, Aspeslagh, Sandrine

Source: Journal of immunotherapy and precision oncology. 3(1):27-30

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114595015.0x000001&indx=1&recIds=ETOCvdc_100114595015.0x000001

Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report.

Authors: Simeni Njonnou, Sylvain Raoul^1,2,3 (AUTHOR) raoulsims@yahoo.fr, Aspeslagh, Sandrine⁴ (AUTHOR), Ntsama Essomba, Marie-Josiane⁵ (AUTHOR), Racu, Marie-Lucie⁶ (AUTHOR), Kemta Lekpa, Fernando¹ (AUTHOR), Vandergheynst, Frédéric² (AUTHOR)

Source: Journal of Medical Case Reports. 12/9/2022, Vol. 16 Issue 1, p1-8. 8p.

Subject Terms: *SIALADENITIS, *ADRENOCORTICOTROPIC hormone, *HORMONE deficiencies, *DRUG side effects, *IMMUNE checkpoint inhibitors, *SJOGREN'S syndrome

Cancer immunotherapy-associated hypophysitis

Authors: Solinas, Cinzia, Porcu, Michele, De Silva, Pushpamali, Musi, Marco, Aspeslagh, Sandrine, Scartozzi, Mario, Willard-Gallo, Karen, Mariotti, Stefano, Saba, Luca

Source: In Seminars in Oncology June 2018 45(3):181-186

Bilateral Corneal Perforation in a Patient Under Anti-PD1 Therapy

Authors: Ramaekers, Anaïs, Aspeslagh, Sandrine, De Brucker, Nele, Van Mierlo, Camille, ten Tusscher, Marcel, Schauwvlieghe, Pieter-Paul, Termote, Karolien

Source: Cornea. 40(2):245-247

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190013265.0x000001&indx=1&recIds=ETOCvdc_100190013265.0x000001

Are phase I trials safe for older patients?

Authors: Baldini, Capucine, Le Saux, Olivia, Helissey, Carole, Aspeslagh, Sandrine, Castanon, Eduardo, Varga, Andrea, Gazzah, Anas, Bahleda, Rastilav, Mir, Olivier, Massard, Christophe, Soria, Jean-Charles, Hollebecque, Antoine

Source: In Journal of Geriatric Oncology March 2018 9(2):87-92